Results for tag: "Zinplava"

Zinplava is a type of antibiotic used to treat certain bacterial infections. It is a liposomal formulation of bezlotoxumab, a monoclonal antibody that binds to and neutralizes Clostridium difficile toxin B. It is used in combination with other antibiotics to reduce the recurrence of C. difficile infection (CDI) in adults. Zinplava is administered as an intravenous infusion and is approved for use in the United States, Canada, and Europe. The Zinplava market is a rapidly growing segment of the antibiotics market. It is driven by the increasing prevalence of CDI, which is a major cause of morbidity and mortality in hospitalized patients. The market is expected to benefit from the increasing adoption of Zinplava in clinical practice and the launch of new products. Companies in the Zinplava market include Merck & Co., Inc., Pfizer, Inc., and Allergan plc. Show Less Read more